Planet 13 Holdings (PLNH) Net Cash Flow (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Net Cash Flow of $682006.0 for Q1 2026, up 108.71% year-over-year from $326768.2 in Q1 2025, and up 142.46% quarter-over-quarter from -$1.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Net Cash Flow (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Net Cash Flow for 6 consecutive years, with $682006.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 108.71% year-over-year to $682006.0; the TTM figure through Mar 2026 stood at -$1.4 million (up 74.11% YoY), while the FY2025 annual figure was -$9.9 million, down 220.93% from the prior year.
- Net Cash Flow advanced to $682006.0 in Q1 2026 per PLNH's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $5.9 million in Q2 2024 and bottomed at -$14.4 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$2.5 million across 5 years, with a median of -$1.8 million in 2022.
- Annual changes were most pronounced in 2023 — Net Cash Flow slumped 647.44% — and 2024, when it surged 339.16%.
- Planet 13 Holdings' Net Cash Flow stood at -$2.0 million in 2022, then sank by 61.74% to -$3.2 million in 2023, then slipped by 25.48% to -$4.0 million in 2024, then surged by 60.11% to -$1.6 million in 2025, then surged by 142.46% to $682006.0 in 2026.
- Business Quant data shows PLNH's Net Cash Flow at $682006.0 in Q1 2026, -$1.6 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Planet 13 Holdings | 54.56 Mn | 38.08 Mn | 12.32 Mn | 224,202.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 224,202.00 |
| Jun 30, 2026 | 224,202.00 |
| Mar 31, 2026 | 682,006.00 |
| Mar 31, 2026 | 682,006.00 |
| Dec 31, 2025 | -1.61 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Mar 31, 2025 | -7.83 Mn |
| Mar 31, 2025 | -7.83 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Sep 30, 2024 | 741,313.00 |
| Sep 30, 2024 | 741,313.00 |
| Jun 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.90 Mn |
| Mar 31, 2024 | 5.54 Mn |
| Mar 31, 2024 | 5.54 Mn |